Evidence map›Paper›PMID 24312715›Full record

Trial reportGut and liver2013

A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility study.

Hiroyuki Isayama, Kazumichi Kawakubo, Yousuke Nakai, Kouta Inoue, Chimyon Gon, Saburo Matsubara, Hirofumi Kogure, Yukiko Ito, Takeshi Tsujino, Suguru Mizuno and 10 more

Open access · diamondAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Gut and liver, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Hiroyuki IsayamaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kazumichi Kawakubo
Yousuke Nakai
Kouta Inoue
Chimyon Gon
Saburo Matsubara
Hirofumi Kogure
Yukiko Ito
Takeshi Tsujino
Suguru Mizuno
Tsuyoshi Hamada
Rie Uchino
Koji Miyabayashi
Keisuke Yamamoto
Takashi Sasaki
Natsuyo Yamamoto
Kenji Hirano
Naoki Sasahira
Minoru Tada
Kazuhiko Koike
The University of Tokyo · JPJapanese Red Cross Medical Center · JPKanto Central Hospital · JPTokyo Metropolitan Police Hospital · JPUniversity hospital Medical Information Network · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsStent migration occurs frequently, but the prevention of complications resulting from covered self-expandable metal stents (C-SEMSs) remains unresolved. We prospectively assessed a newly developed C-SEMS, a modified covered Zeo stent (m-CZS), in terms of its antimigration effect.

methodsBetween February 2010 and January 2011, an m-CZS was inserted into 42 patients (31 initial drainage cases and 11 reintervention cases) at a tertiary referral center and three affiliated hospitals. The laser-cut stent was flared for 1.5 cm at both ends, with a 1 cm raised bank located 1 cm in from each flared end. The main outcome of this study was the rate of stent migration, and secondary outcomes were the rate of recurrent biliary obstruction (RBO), the time to RBO, the frequencies of complications, and overall survival.

resultsOf the 31 patients with initial drainage, stent migration occurred in four (12.9%, 95% confidence interval, 5.1% to 29.0%), with a mean time of 131 days. RBO occurred in 18 (58%), with a median time to RBO of 107 days. Following previous C-SEMS migration, seven of 10 patients (70%) did not experience m-CZS migration until death.

conclusionsm-CZSs with antimigration properties effectively, although not completely, prevented stent migration after stent insertion.

Indexed as

Prosthesis FailureStentsAgedAged, 80 and overAlloysCarcinomaCholestasisDigestive System NeoplasmsDrainageEquipment DesignFeasibility StudiesFemaleHumansKaplan-Meier EstimateLymphatic MetastasisMaleAlloysnitinolCholangiographyCholestasis, extrahepaticEndoscopic retrogradeStents

Identifiers

PMID24312715
PMCPMC3848551
OpenAlexW2001442206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.